Context Therapeutics Shares Drop After Raising $31M Via Equity

Newly listed Context Therapeutics Inc CNTX has announced a private placement of $31.25 million. The placement includes 5 million shares together with warrants to purchase 5 million shares.

  • Each share of common stock and accompanying Warrant has an offer price of $6.25. 
  • The Warrants have a five and one-half year term and an exercise price of $6.25 per share. 
  • The private placement will close by December 6.
  • In October, Context Therapeutics started trading at NASDAQ after pricing the IPO at $5.00 per share, for gross proceeds of $25.0 million.
  • During IPO, the Company said it would use the proceeds to fund the development of ONA-XR, including three ongoing Phase 2 trials, Phase 1b/2 trial, and two Phase 0 trials.
  • Price Action: CNTX shares are down 13.10% at $6.22 during the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsHealth CareFinancingOfferingsMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!